Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
CNY 63.1
(1.25%)
CNY 63.1
(1.25%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.82 Million CNY | -6.78% |
| 2022 | 1.95 Million CNY | -63.75% |
| 2021 | 5.39 Million CNY | -55.87% |
| 2020 | 12.22 Million CNY | -88.89% |
| 2019 | 110 Million CNY | -12.0% |
| 2018 | 125 Million CNY | 108.33% |
| 2017 | 60 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 1.1 Million CNY | -64.02% |
| 2024 Q2 | 1.3 Million CNY | -12.79% |
| 2024 Q1 | 1.5 Million CNY | -17.64% |
| 2023 Q4 | 1.82 Million CNY | -11.7% |
| 2023 FY | 1.82 Million CNY | -6.78% |
| 2023 Q3 | 2.06 Million CNY | -16.89% |
| 2023 Q1 | 2.48 Million CNY | 26.98% |
| 2023 Q2 | 2.48 Million CNY | 0.03% |
| 2022 Q2 | 2.39 Million CNY | -17.02% |
| 2022 Q1 | 2.89 Million CNY | -46.4% |
| 2022 Q4 | 1.95 Million CNY | -12.15% |
| 2022 FY | 1.95 Million CNY | -63.75% |
| 2022 Q3 | 2.22 Million CNY | -7.21% |
| 2021 Q2 | 8.88 Million CNY | -18.96% |
| 2021 Q3 | 6.47 Million CNY | -27.14% |
| 2021 FY | 5.39 Million CNY | -55.87% |
| 2021 Q1 | 10.95 Million CNY | -10.35% |
| 2021 Q4 | 5.39 Million CNY | -16.63% |
| 2020 Q1 | - CNY | -100.0% |
| 2020 FY | 12.22 Million CNY | -88.89% |
| 2020 Q4 | 12.22 Million CNY | 0.0% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 FY | 110 Million CNY | -12.0% |
| 2019 Q4 | 110 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 125 Million CNY | 108.33% |
| 2017 FY | 60 Million CNY | 0.0% |